Identifies themes and clusters of stock movements
Market TodayThemes and Stocks SummaryThematic Stock SearchClick here for daily refresh schedule
BIO - Bio-Rad Laboratories Inc.
$601.15
8.01(1.35%)9:00:02 PM 1/15/2021
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide. Bio-Rad’s life science products primarily include instruments, software, consumables, reagents, and content for the areas of cell biology, gene expression, protein purification, protein quantitation, drug discovery and manufacture, food safety, and science education. These products are based on technologies to separate, purify, identify, analyze, and amplify biological materials such as antibodies, proteins, nucleic acids, cells, and bacteria.
Stock Chart

Summary:

  • A moving average of Short volume ratio is at a recent 2 week high. A high short volume ratio indicate selling presures.
  • MACD is crossing MACD signal line at 0.2. MACD crossing signal line is bullish signal.

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Related Topics
leak data

Related Topics

Peers

Stock news

    01/10/2021BIO
    A Trio of High Earnings Return Stocks

    They are thrashing the 20-year high-quality market corporate bonds

    01/8/2021BIO
    Bio-Rad to Participate in Fireside Chat at the 39th Annual J.P. Morgan Healthcare Conference on January 11

    Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO; Andrew Last, Executive Vice President and COO; and Ilan Daskal, Executive Vice President and CFO will participate virtually in a Fireside Chat at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, at 1:30 PM (PST).

    12/22/2020BIO
    Top Healthcare Stocks for January 2021

    These are the healthcare stocks with the best value, fastest growth, and most momentum for January 2021.

    12/21/2020BIO
    Bio Rad Labs Sees Composite Rating Improve To 96

    Bio Rad Labs saw its IBD SmartSelect Composite Rating rise to 96 Monday, up from 94 the day before. The upgrade means the stock is now outpacing 96% of all other stocks in terms of key performance metrics and technical strength. Bio Rad Labs is currently forming a cup without handle, with a 648.49 entry.

    12/21/2020BIO
    A Look Into Healthcare Sector Value Stocks

    What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.Below is a list of notable value stocks in the healthcare sector: 1. AIkido Pharma (NASDAQ:AIKI) - P/E: 3.26 2. Bio-Rad Laboratories (NYSE:BIO) - P/E: 5.19 3. Coherus BioSciences (NASDAQ:CHRS) - P/E: 8.47 4....

    12/15/2020BIO
    Is BIO A Good Stock To Buy Now?

    Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 817 active prominent money managers and analyze their quarterly 13F filings. The stocks that are heavily bought by hedge funds historically outperformed the market, though there is no shortage of high profile […]

    12/11/2020BIO
    The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street

    Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 10) * Adaptive Biotechnologies Corp (NASDAQ: ADPT) * ALX Oncology Holdings Inc (NASDAQ: ALXO) * Anixa Biosciences Inc (NASDAQ: ANIX) * Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) * Beam Therapeutics Inc (NASDAQ: BEAM) * Bioanalytical Systems, Inc. (NASDAQ: BASI) * BioLife Solutions Inc (NASDAQ: BLFS) * BioNTech SE's - ADR (NASDAQ: BNTX) * BioTele...

    12/10/2020BIO
    Bio-Rad Provides Outlook Through 2023

    Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announced today its outlook through 2023, which shows the company’s commitment to continued organic growth, continued margin expansion, and its efforts on sustainability measures.

    12/4/2020BIO
    Cooper Companies (COO) Q4 Earnings & Revenues Top Estimates

    Cooper Companies' (COO) fiscal fourth-quarter earnings reflect weak segmental performance. However, it exceeds expectation as it witnesses faster-than-anticipated recovery.